Search results
Results from the WOW.Com Content Network
Vemurafenib was approved in the United States for the treatment of late-stage melanoma in August 2011, [23] making it the first drug designed using fragment-based lead discovery to gain regulatory approval. [24] Vemurafenib was approved for use in Canada in February 2012. [25]
Lurasidone was first approved for medical use in the United States in 2010. [2] In 2013, it was approved in Canada and by the U.S. Food and Drug Administration (FDA) to treat bipolar depression, either as monotherapy or adjunctively with lithium or valproate.
On September 22, 2014, the U.S. Food and Drug Administration (FDA) issued an FDA Warning Letter to doTerra for its distributors marketing products as possible treatments or cures for Ebola, cancer, autism, and other conditions in violation of the Food, Drug and Cosmetic Act. [6] [26] [27] [28] Federal agents conducted an investigation of ...
(Reuters) -The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it the company's first wholly-owned drug, the health regulator's ...
A study in The BMJ, with over 1.6 million women, found that users of vaginal rings with ethinylestradiol and etonogestrel have a 6.5 times increased risk of venous thrombosis compared to non-users. [ 19 ] [ 20 ] Epidemiological studies have shown that oral contraceptives that contain desogestrel can increase the risk of blood clots (venous ...
The U.S. Food and Drug Administration (FDA) on Tuesday published letters warning two online vendors to stop selling unapproved versions of semaglutide and tirzepatide, the active ingredients in ...
[63] [65] On 9 October 1987, following worldwide clinical trials in 20,000 women of mifepristone with a prostaglandin analogue (initially sulprostone or gemeprost, later misoprostol) for medical abortion, Roussel-Uclaf sought approval in France for their use for medical abortion, with approval announced on 23 September 1988.
Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...